About SKQ Project
In 2004, a new substance was synthesized by the group of professor Vladimir P. Skulachev in the Moscow State
University. Our project team later gave the substance its “production” name “SkQ1". Two commercial
entities Mitotech Russia and Mitotech EU were established around 2010 with an aim to
develop SkQ1 into a drug targeting several age-related indications.